К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

The FOLFIRINOX regimen: intensive chemotherapy for pancreatic cancer

FOLFIRINOX is a four-drug regimen: fluorouracil, leucovorin, irinotecan and oxaliplatin. Who it suits, how mFOLFIRINOX differs and why side-effect prevention matters.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026

In short

FOLFIRINOX is an intensive chemotherapy regimen of four drugs: FOLinic acid (leucovorin), Fluorouracil, IRINotecan and OXaliplatin. Its main use is pancreatic cancer.

How it appears in your prescription

  • ‘mFOLFIRINOX every 14 days × 12 cycles’ — after pancreatic surgery.
  • ‘FOLFIRINOX before surgery’ — for borderline resectable or locally advanced tumors.
  • ‘FOLFIRINOX + G-CSF’ — with neutropenia prevention.

What it means

According to the US National Cancer Institute, FOLFIRINOX is used in pancreatic cancer — after surgery, before it and for metastatic disease. A cycle lasts 14 days: the drugs are given by drip on day 1, then fluorouracil by pump for about 46 hours. It suits people in good condition on the ECOG scale.

Side effects

Diarrhea from irinotecan (early — during the infusion — and late, a few days later), low neutrophils with a risk of febrile neutropenia, neuropathy from oxaliplatin, nausea and marked fatigue. G-CSF is often prescribed.

Questions to ask your doctor

  • Why does FOLFIRINOX suit me rather than a gemcitabine-based regimen?
  • Which tablets should I keep at home for diarrhea, and when do I start them?
  • Do I need G-CSF prevention?

Sources

  1. FOLFIRINOX — National Cancer Institute
  2. Pancreatic Cancer Treatment (PDQ) — National Cancer Institute
  3. WBC Growth Factors: ASCO Guideline Update — ASCO

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles